Found 10 matching trials
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
PHASE3The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Location
Forest Investigative Site 055
Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD
PHASE3This study's primary objective is to compare the efficacy and tolerability ...
Location
Institute for Advanced Medical Research
Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder
PHASE3The objective of this study is to evaluate the efficacy, safety, and tolera...
Location
Woodland International Research Group
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
PHASE3The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Location
Forest Investigative Site
Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder
PHASE3The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
PHASE4This study evaluates the efficacy, safety and tolerability of levomilnacipr...
Location
Forest Investigative Site 053
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
PHASE3The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Location
Forest Investigative Site
Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder
PHASE3The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Location
Forest Investigative Site 039
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder
PHASE2The purpose of the study is to evaluate the efficacy, safety and tolerabili...
Location
Forest Investigative Site 010
Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder
PHASE3The purpose of this study is to evaluate the safety and efficacy of Levomil...
Location
Forest Investigative Site #023